Top Companies in AI in Pathology Market

The global AI in pathology market is projected to reach USD 347.4 million by 2030 from USD 107.4 million in 2025, at a high CAGR of 26.5 % during the forecast period. According to a journal published in 2023 by BMJ-Quality & Safety, it is estimated that 800,000 Americans undergo incorrect diagnoses yearly, causing the death of 371,000 patients and permanent disabilities to 424,000. Artificial intelligence could help with the rising workloads of pathologists while simultaneously providing consistent and timely diagnostic care.

Prominent players in the AI in pathology market include Koninklijke Philips N.V. (Netherlands), F. Hoffmann-La Roche Ltd (Switzerland), Hologic, Inc. (US), Akoya Biosciences, Inc. (US), Aiforia Technologies Plc (Finland), Indica Labs Inc. (US), OptraScan (US), Ibex Medical Analytics Ltd. (Israel), Mindpeak GmbH (Germany), and Tribun Health (France).

To know about the assumptions considered for the study download the pdf brochure

F. Hoffmann-La Roche Ltd. (Switzerland)

F. Hoffmann-La Roche Ltd. has been spending significantly on research & development to enhance the existing portfolio, as it has a broad product portfolio for developing AI in pathology market. The company attains its target of quick growth by developing and launching new and advanced products in the market to attract more partnerships and collaborations. In September 2024, Roche launched advanced AI algorithm software that provides beneficial insights into pathology for targeted treatments for cancer patients.

Koninklijke Philips N.V. (Netherlands)

Koninklijke Philips N.V. has an established geographic presence and a strong sales & distribution network worldwide. It invests in R&D activities to add technologically innovative solutions to its portfolio. In 2023, the company invested nearly USD 2.04 billion in R&D activities. It focuses on collaborating and partnering with other market players to expand its presence globally and enhance its product portfolio. In March 2024, the company expanded its collaboration with Amazon Web Services (AWS) to meet the increasing demand for secure, scalable digital pathology solutions in the cloud.

Hologic, Inc. (US)

Hologic, Inc. provides software solutions to hospitals and healthcare systems that promote AI in pathology solutions for better patient care. These include cytology systems such as the Genius Digital Diagnostics System. The company has adopted organic strategies such as product approval to enhance its geographic presence and increase the adoption of its AI in pathology solutions. In February 2024, Hologic, Inc. announced that the US Food and Drug Administration (FDA) cleared its new Genius Digital Diagnostics System, featuring the Genius Cervical AI algorithm. It is the first FDA-approved digital cytology solution that integrates deep learning AI with advanced volumetric imaging technology to detect pre-cancerous lesions and cervical cancer cells.

MARKET RANKING

The ranking of companies in the AI in pathology market has been determined through a market share analysis conducted after thorough secondary research and validated by primary respondents. This ranking considers parameters such as revenue from AI in pathology, product portfolio breadth and depth, innovation, and launches. Based on this analysis, the top players leading the market are Koninklijke Philips N.V. (Netherlands), F. Hoffmann-La Roche Ltd. (Switzerland), Hologic, Inc. (US), Akoya Biosciences, Inc. (US), and Aiforia Technologies Plc (Finland).

These companies rely on their strong R&D capabilities, diversified product portfolio, global reach, and continuous innovation in the AI in pathology market. Koninklijke Philips N.V. maintains a strong position utilizing AI to deliver innovative tools across various areas, including diagnostic imaging. It strategically focuses on strong research & development activities to remain competitive.

F. Hoffman-La Roche Ltd. is engaged in the innovation & manufacture of instruments and software that automate tissue processing and image analysis for cancer diagnostics. The company undertakes partnership and collaboration exercises with key local players in the target market to expand its presence in high-growth potential markets. For instance, in February 2024, PathAI collaborated with Roche Tissue Diagnostics (RTD) to create AI-powered digital pathology algorithms for the companion diagnostics division. These image analysis algorithms will be implemented on the Roche Navify Digital Pathology platform, ensuring smooth integration into pathology labs globally.

Related Reports:

Al in Pathology Market by Neural Network (GAN, CNN, RNN), Function (Diagnostic, Image Analysis, CDSS, Data Management, Analytics), Use Case (Drug Discovery, Clinical Workflow), End User (Hospitals, Labs, Pharma/Biotech), & Region - Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com